nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—myenteric nerve plexus—stomach cancer	0.0693	0.24	CbGeAlD
Droperidol—HTR2A—vagus nerve—stomach cancer	0.0462	0.16	CbGeAlD
Droperidol—HTR2A—vein—stomach cancer	0.0446	0.155	CbGeAlD
Droperidol—Hypovolaemia—Irinotecan—stomach cancer	0.0255	0.056	CcSEcCtD
Droperidol—Sudden death—Irinotecan—stomach cancer	0.0154	0.0339	CcSEcCtD
Droperidol—Sudden death—Fluorouracil—stomach cancer	0.0148	0.0325	CcSEcCtD
Droperidol—Akathisia—Irinotecan—stomach cancer	0.0143	0.0314	CcSEcCtD
Droperidol—Shivering—Capecitabine—stomach cancer	0.0142	0.0312	CcSEcCtD
Droperidol—HTR2A—blood vessel—stomach cancer	0.0142	0.0492	CbGeAlD
Droperidol—ADRA1A—hematopoietic system—stomach cancer	0.0117	0.0405	CbGeAlD
Droperidol—Altered state of consciousness—Capecitabine—stomach cancer	0.0114	0.0252	CcSEcCtD
Droperidol—KCNH2—hematopoietic system—stomach cancer	0.0113	0.0391	CbGeAlD
Droperidol—ADRA1A—epithelium—stomach cancer	0.0107	0.037	CbGeAlD
Droperidol—Sudden death—Capecitabine—stomach cancer	0.0103	0.0227	CcSEcCtD
Droperidol—Drowsiness—Mitomycin—stomach cancer	0.0102	0.0224	CcSEcCtD
Droperidol—Anaphylactic shock—Floxuridine—stomach cancer	0.00827	0.0182	CcSEcCtD
Droperidol—ADRA1A—lymphoid tissue—stomach cancer	0.00821	0.0285	CbGeAlD
Droperidol—Sudden death—Methotrexate—stomach cancer	0.00769	0.0169	CcSEcCtD
Droperidol—Fluspirilene—ADRB1—stomach cancer	0.00754	0.31	CrCbGaD
Droperidol—HTR2A—hematopoietic system—stomach cancer	0.00754	0.0262	CbGeAlD
Droperidol—Torsade de pointes—Capecitabine—stomach cancer	0.00754	0.0166	CcSEcCtD
Droperidol—KCNH2—bone marrow—stomach cancer	0.00722	0.0251	CbGeAlD
Droperidol—Syncope—Mitomycin—stomach cancer	0.00713	0.0157	CcSEcCtD
Droperidol—Loss of consciousness—Mitomycin—stomach cancer	0.00699	0.0154	CcSEcCtD
Droperidol—HTR2A—epithelium—stomach cancer	0.0069	0.0239	CbGeAlD
Droperidol—Hypertension—Mitomycin—stomach cancer	0.00686	0.0151	CcSEcCtD
Droperidol—Fluspirilene—HTR1A—stomach cancer	0.00675	0.277	CrCbGaD
Droperidol—ADRA1A—endocrine gland—stomach cancer	0.0067	0.0233	CbGeAlD
Droperidol—HTR2A—smooth muscle tissue—stomach cancer	0.00664	0.0231	CbGeAlD
Droperidol—DRD2—endocrine gland—stomach cancer	0.00657	0.0228	CbGeAlD
Droperidol—Body temperature increased—Floxuridine—stomach cancer	0.00654	0.0144	CcSEcCtD
Droperidol—KCNH2—endocrine gland—stomach cancer	0.00648	0.0225	CbGeAlD
Droperidol—Shock—Mitomycin—stomach cancer	0.00638	0.014	CcSEcCtD
Droperidol—Amenorrhoea—Docetaxel—stomach cancer	0.00621	0.0137	CcSEcCtD
Droperidol—Hypersensitivity—Floxuridine—stomach cancer	0.00609	0.0134	CcSEcCtD
Droperidol—ADRA1A—liver—stomach cancer	0.00604	0.021	CbGeAlD
Droperidol—Somnolence—Mitomycin—stomach cancer	0.00577	0.0127	CcSEcCtD
Droperidol—Blood pressure increased—Docetaxel—stomach cancer	0.00546	0.012	CcSEcCtD
Droperidol—Cardiac arrest—Irinotecan—stomach cancer	0.00545	0.012	CcSEcCtD
Droperidol—Blood pressure increased—Capecitabine—stomach cancer	0.00529	0.0116	CcSEcCtD
Droperidol—HTR2A—digestive system—stomach cancer	0.00525	0.0182	CbGeAlD
Droperidol—Cardiac arrest—Fluorouracil—stomach cancer	0.00522	0.0115	CcSEcCtD
Droperidol—Rash—Floxuridine—stomach cancer	0.00521	0.0115	CcSEcCtD
Droperidol—Dermatitis—Floxuridine—stomach cancer	0.00521	0.0114	CcSEcCtD
Droperidol—Body temperature increased—Mitomycin—stomach cancer	0.00513	0.0113	CcSEcCtD
Droperidol—Pimozide—HTR1A—stomach cancer	0.00505	0.207	CrCbGaD
Droperidol—Fenbufen—PTGS2—stomach cancer	0.00501	0.206	CrCbGaD
Droperidol—Ventricular arrhythmia—Epirubicin—stomach cancer	0.00498	0.0109	CcSEcCtD
Droperidol—Ventricular arrhythmia—Doxorubicin—stomach cancer	0.0046	0.0101	CcSEcCtD
Droperidol—KCNH2—lymph node—stomach cancer	0.00448	0.0155	CbGeAlD
Droperidol—HTR2A—endocrine gland—stomach cancer	0.00433	0.015	CbGeAlD
Droperidol—Dizziness—Mitomycin—stomach cancer	0.00429	0.00943	CcSEcCtD
Droperidol—Amenorrhoea—Epirubicin—stomach cancer	0.00419	0.00921	CcSEcCtD
Droperidol—Rash—Mitomycin—stomach cancer	0.00409	0.00899	CcSEcCtD
Droperidol—Dermatitis—Mitomycin—stomach cancer	0.00409	0.00898	CcSEcCtD
Droperidol—HTR2A—liver—stomach cancer	0.00391	0.0136	CbGeAlD
Droperidol—Amenorrhoea—Doxorubicin—stomach cancer	0.00388	0.00852	CcSEcCtD
Droperidol—Ventricular tachycardia—Epirubicin—stomach cancer	0.00368	0.0081	CcSEcCtD
Droperidol—Cardiac arrest—Capecitabine—stomach cancer	0.00365	0.00802	CcSEcCtD
Droperidol—Chills—Irinotecan—stomach cancer	0.00356	0.00782	CcSEcCtD
Droperidol—Gynaecomastia—Methotrexate—stomach cancer	0.00352	0.00774	CcSEcCtD
Droperidol—Ventricular tachycardia—Doxorubicin—stomach cancer	0.00341	0.00749	CcSEcCtD
Droperidol—Bronchospasm—Docetaxel—stomach cancer	0.00337	0.00741	CcSEcCtD
Droperidol—Bronchospasm—Capecitabine—stomach cancer	0.00326	0.00717	CcSEcCtD
Droperidol—Syncope—Irinotecan—stomach cancer	0.0031	0.00681	CcSEcCtD
Droperidol—Loss of consciousness—Irinotecan—stomach cancer	0.00303	0.00667	CcSEcCtD
Droperidol—Hyperglycaemia—Capecitabine—stomach cancer	0.00299	0.00658	CcSEcCtD
Droperidol—Hypertension—Irinotecan—stomach cancer	0.00298	0.00655	CcSEcCtD
Droperidol—Depression—Capecitabine—stomach cancer	0.00295	0.00648	CcSEcCtD
Droperidol—Anaphylactic shock—Irinotecan—stomach cancer	0.00282	0.00619	CcSEcCtD
Droperidol—Shock—Irinotecan—stomach cancer	0.00277	0.00609	CcSEcCtD
Droperidol—Anaphylactic shock—Fluorouracil—stomach cancer	0.0027	0.00593	CcSEcCtD
Droperidol—Tachycardia—Fluorouracil—stomach cancer	0.00263	0.00579	CcSEcCtD
Droperidol—Hypotension—Irinotecan—stomach cancer	0.00263	0.00579	CcSEcCtD
Droperidol—Cardiac arrest—Epirubicin—stomach cancer	0.00254	0.00559	CcSEcCtD
Droperidol—Hypotension—Fluorouracil—stomach cancer	0.00252	0.00554	CcSEcCtD
Droperidol—Somnolence—Irinotecan—stomach cancer	0.00251	0.00551	CcSEcCtD
Droperidol—Chills—Docetaxel—stomach cancer	0.00246	0.00541	CcSEcCtD
Droperidol—Somnolence—Fluorouracil—stomach cancer	0.0024	0.00527	CcSEcCtD
Droperidol—Chills—Capecitabine—stomach cancer	0.00238	0.00524	CcSEcCtD
Droperidol—Cardiac arrest—Doxorubicin—stomach cancer	0.00235	0.00517	CcSEcCtD
Droperidol—Body temperature increased—Irinotecan—stomach cancer	0.00223	0.0049	CcSEcCtD
Droperidol—Drowsiness—Methotrexate—stomach cancer	0.0022	0.00484	CcSEcCtD
Droperidol—Depression—Methotrexate—stomach cancer	0.00219	0.00482	CcSEcCtD
Droperidol—Syncope—Docetaxel—stomach cancer	0.00214	0.0047	CcSEcCtD
Droperidol—Body temperature increased—Fluorouracil—stomach cancer	0.00213	0.00469	CcSEcCtD
Droperidol—Palpitations—Docetaxel—stomach cancer	0.00211	0.00464	CcSEcCtD
Droperidol—Loss of consciousness—Docetaxel—stomach cancer	0.0021	0.00461	CcSEcCtD
Droperidol—Hyperglycaemia—Epirubicin—stomach cancer	0.00208	0.00458	CcSEcCtD
Droperidol—Hypersensitivity—Irinotecan—stomach cancer	0.00208	0.00456	CcSEcCtD
Droperidol—Syncope—Capecitabine—stomach cancer	0.00207	0.00456	CcSEcCtD
Droperidol—Hypertension—Docetaxel—stomach cancer	0.00206	0.00453	CcSEcCtD
Droperidol—Drowsiness—Epirubicin—stomach cancer	0.00206	0.00453	CcSEcCtD
Droperidol—Palpitations—Capecitabine—stomach cancer	0.00204	0.00449	CcSEcCtD
Droperidol—Loss of consciousness—Capecitabine—stomach cancer	0.00203	0.00446	CcSEcCtD
Droperidol—Hypertension—Capecitabine—stomach cancer	0.002	0.00439	CcSEcCtD
Droperidol—Hypersensitivity—Fluorouracil—stomach cancer	0.00199	0.00437	CcSEcCtD
Droperidol—Anxiety—Capecitabine—stomach cancer	0.00196	0.00431	CcSEcCtD
Droperidol—Anaphylactic shock—Docetaxel—stomach cancer	0.00195	0.00428	CcSEcCtD
Droperidol—Hyperglycaemia—Doxorubicin—stomach cancer	0.00193	0.00424	CcSEcCtD
Droperidol—Shock—Docetaxel—stomach cancer	0.00192	0.00421	CcSEcCtD
Droperidol—Drowsiness—Doxorubicin—stomach cancer	0.00191	0.00419	CcSEcCtD
Droperidol—Tachycardia—Docetaxel—stomach cancer	0.0019	0.00418	CcSEcCtD
Droperidol—Dizziness—Irinotecan—stomach cancer	0.00186	0.0041	CcSEcCtD
Droperidol—Shock—Capecitabine—stomach cancer	0.00186	0.00408	CcSEcCtD
Droperidol—Tachycardia—Capecitabine—stomach cancer	0.00184	0.00405	CcSEcCtD
Droperidol—Hypotension—Docetaxel—stomach cancer	0.00182	0.004	CcSEcCtD
Droperidol—Dizziness—Fluorouracil—stomach cancer	0.00178	0.00392	CcSEcCtD
Droperidol—Rash—Irinotecan—stomach cancer	0.00178	0.00391	CcSEcCtD
Droperidol—Dermatitis—Irinotecan—stomach cancer	0.00178	0.0039	CcSEcCtD
Droperidol—Chills—Methotrexate—stomach cancer	0.00177	0.0039	CcSEcCtD
Droperidol—Hypotension—Capecitabine—stomach cancer	0.00176	0.00387	CcSEcCtD
Droperidol—Somnolence—Docetaxel—stomach cancer	0.00173	0.00381	CcSEcCtD
Droperidol—Rash—Fluorouracil—stomach cancer	0.0017	0.00374	CcSEcCtD
Droperidol—Dermatitis—Fluorouracil—stomach cancer	0.0017	0.00374	CcSEcCtD
Droperidol—Chills—Epirubicin—stomach cancer	0.00166	0.00365	CcSEcCtD
Droperidol—Body temperature increased—Docetaxel—stomach cancer	0.00154	0.00338	CcSEcCtD
Droperidol—Chills—Doxorubicin—stomach cancer	0.00154	0.00337	CcSEcCtD
Droperidol—Body temperature increased—Capecitabine—stomach cancer	0.00149	0.00328	CcSEcCtD
Droperidol—Syncope—Epirubicin—stomach cancer	0.00144	0.00317	CcSEcCtD
Droperidol—Hypersensitivity—Docetaxel—stomach cancer	0.00144	0.00315	CcSEcCtD
Droperidol—Palpitations—Epirubicin—stomach cancer	0.00142	0.00313	CcSEcCtD
Droperidol—Loss of consciousness—Epirubicin—stomach cancer	0.00141	0.00311	CcSEcCtD
Droperidol—Anaphylactic shock—Methotrexate—stomach cancer	0.0014	0.00309	CcSEcCtD
Droperidol—Hypertension—Epirubicin—stomach cancer	0.00139	0.00306	CcSEcCtD
Droperidol—Hypersensitivity—Capecitabine—stomach cancer	0.00139	0.00305	CcSEcCtD
Droperidol—Anxiety—Epirubicin—stomach cancer	0.00137	0.003	CcSEcCtD
Droperidol—Syncope—Doxorubicin—stomach cancer	0.00134	0.00294	CcSEcCtD
Droperidol—Palpitations—Doxorubicin—stomach cancer	0.00132	0.00289	CcSEcCtD
Droperidol—Anaphylactic shock—Epirubicin—stomach cancer	0.00131	0.00289	CcSEcCtD
Droperidol—Hypotension—Methotrexate—stomach cancer	0.00131	0.00288	CcSEcCtD
Droperidol—Loss of consciousness—Doxorubicin—stomach cancer	0.00131	0.00288	CcSEcCtD
Droperidol—Shock—Epirubicin—stomach cancer	0.00129	0.00284	CcSEcCtD
Droperidol—Dizziness—Docetaxel—stomach cancer	0.00129	0.00283	CcSEcCtD
Droperidol—Hypertension—Doxorubicin—stomach cancer	0.00129	0.00283	CcSEcCtD
Droperidol—Tachycardia—Epirubicin—stomach cancer	0.00128	0.00282	CcSEcCtD
Droperidol—Anxiety—Doxorubicin—stomach cancer	0.00126	0.00278	CcSEcCtD
Droperidol—Somnolence—Methotrexate—stomach cancer	0.00125	0.00274	CcSEcCtD
Droperidol—Dizziness—Capecitabine—stomach cancer	0.00125	0.00274	CcSEcCtD
Droperidol—Rash—Docetaxel—stomach cancer	0.00123	0.0027	CcSEcCtD
Droperidol—Hypotension—Epirubicin—stomach cancer	0.00123	0.0027	CcSEcCtD
Droperidol—Dermatitis—Docetaxel—stomach cancer	0.00123	0.0027	CcSEcCtD
Droperidol—Anaphylactic shock—Doxorubicin—stomach cancer	0.00122	0.00267	CcSEcCtD
Droperidol—Shock—Doxorubicin—stomach cancer	0.0012	0.00263	CcSEcCtD
Droperidol—Rash—Capecitabine—stomach cancer	0.00119	0.00261	CcSEcCtD
Droperidol—Dermatitis—Capecitabine—stomach cancer	0.00119	0.00261	CcSEcCtD
Droperidol—Tachycardia—Doxorubicin—stomach cancer	0.00119	0.00261	CcSEcCtD
Droperidol—Somnolence—Epirubicin—stomach cancer	0.00117	0.00257	CcSEcCtD
Droperidol—Hypotension—Doxorubicin—stomach cancer	0.00114	0.0025	CcSEcCtD
Droperidol—Body temperature increased—Methotrexate—stomach cancer	0.00111	0.00244	CcSEcCtD
Droperidol—Somnolence—Doxorubicin—stomach cancer	0.00108	0.00238	CcSEcCtD
Droperidol—Body temperature increased—Epirubicin—stomach cancer	0.00104	0.00228	CcSEcCtD
Droperidol—Hypersensitivity—Methotrexate—stomach cancer	0.00103	0.00227	CcSEcCtD
Droperidol—Hypersensitivity—Epirubicin—stomach cancer	0.000968	0.00213	CcSEcCtD
Droperidol—Body temperature increased—Doxorubicin—stomach cancer	0.000961	0.00211	CcSEcCtD
Droperidol—Dizziness—Methotrexate—stomach cancer	0.000928	0.00204	CcSEcCtD
Droperidol—Hypersensitivity—Doxorubicin—stomach cancer	0.000896	0.00197	CcSEcCtD
Droperidol—Rash—Methotrexate—stomach cancer	0.000885	0.00195	CcSEcCtD
Droperidol—Dermatitis—Methotrexate—stomach cancer	0.000884	0.00194	CcSEcCtD
Droperidol—Dizziness—Epirubicin—stomach cancer	0.000869	0.00191	CcSEcCtD
Droperidol—Rash—Epirubicin—stomach cancer	0.000828	0.00182	CcSEcCtD
Droperidol—Dermatitis—Epirubicin—stomach cancer	0.000828	0.00182	CcSEcCtD
Droperidol—Dizziness—Doxorubicin—stomach cancer	0.000804	0.00177	CcSEcCtD
Droperidol—Rash—Doxorubicin—stomach cancer	0.000766	0.00168	CcSEcCtD
Droperidol—Dermatitis—Doxorubicin—stomach cancer	0.000766	0.00168	CcSEcCtD
Droperidol—DRD2—Signaling by GPCR—ANXA1—stomach cancer	0.00017	0.000731	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR1A—stomach cancer	0.00017	0.000729	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKAB1—stomach cancer	0.000169	0.000726	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000168	0.000724	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ANXA1—stomach cancer	0.000167	0.000719	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KISS1—stomach cancer	0.000166	0.000713	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RNF43—stomach cancer	0.000166	0.000713	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKAB1—stomach cancer	0.000165	0.000711	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000165	0.000709	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000165	0.000709	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRB1—stomach cancer	0.000165	0.000708	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ANXA1—stomach cancer	0.000164	0.000704	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KISS1—stomach cancer	0.000163	0.000701	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RNF43—stomach cancer	0.000163	0.000701	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000162	0.000698	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRB1—stomach cancer	0.000162	0.000697	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.00016	0.000689	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.00016	0.000689	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RNF43—stomach cancer	0.00016	0.000687	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KISS1—stomach cancer	0.00016	0.000687	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000159	0.000684	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000159	0.000683	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRB1—stomach cancer	0.000159	0.000682	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000157	0.000674	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000157	0.000674	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000155	0.000668	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000152	0.000654	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000151	0.000651	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000148	0.000637	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FST—stomach cancer	0.000148	0.000635	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRB2—stomach cancer	0.000147	0.000632	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FST—stomach cancer	0.000145	0.000625	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HBEGF—stomach cancer	0.000145	0.000622	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRB2—stomach cancer	0.000145	0.000622	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—TP53—stomach cancer	0.000144	0.00062	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GAST—stomach cancer	0.000143	0.000613	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RGS2—stomach cancer	0.000143	0.000613	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FST—stomach cancer	0.000142	0.000612	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HBEGF—stomach cancer	0.000142	0.000612	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADRB2—stomach cancer	0.000142	0.000609	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GAST—stomach cancer	0.00014	0.000603	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RGS2—stomach cancer	0.00014	0.000603	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HBEGF—stomach cancer	0.000139	0.000599	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000139	0.000598	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RGS2—stomach cancer	0.000137	0.000591	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GAST—stomach cancer	0.000137	0.000591	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000136	0.000585	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGG—stomach cancer	0.000135	0.000581	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRB2—stomach cancer	0.000133	0.000574	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGG—stomach cancer	0.000133	0.000572	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—IL6—stomach cancer	0.000132	0.000568	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRB2—stomach cancer	0.000131	0.000564	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000131	0.000562	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGG—stomach cancer	0.00013	0.00056	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKAA1—stomach cancer	0.00013	0.000559	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PPP2R1A—stomach cancer	0.000129	0.000553	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000129	0.000553	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRB2—stomach cancer	0.000129	0.000553	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKAA1—stomach cancer	0.000128	0.00055	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PPP2R1A—stomach cancer	0.000126	0.000542	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000126	0.000541	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RBP4—stomach cancer	0.000126	0.00054	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CXCL8—stomach cancer	0.000126	0.00054	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKAA1—stomach cancer	0.000125	0.000539	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RBP4—stomach cancer	0.000124	0.000532	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CXCL8—stomach cancer	0.000124	0.000531	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000123	0.000529	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RBP4—stomach cancer	0.000121	0.00052	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CXCL8—stomach cancer	0.000121	0.00052	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000121	0.000518	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HSPB1—stomach cancer	0.000108	0.000465	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGTR2—stomach cancer	0.000108	0.000465	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—F2R—stomach cancer	0.000107	0.000459	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BMP2—stomach cancer	0.000107	0.000459	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HSPB1—stomach cancer	0.000106	0.000457	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGTR2—stomach cancer	0.000106	0.000457	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—F2R—stomach cancer	0.000105	0.000452	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BMP2—stomach cancer	0.000105	0.000452	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKR1C3—stomach cancer	0.000105	0.000452	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGTR2—stomach cancer	0.000104	0.000448	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HSPB1—stomach cancer	0.000104	0.000448	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR1A—stomach cancer	0.000104	0.000447	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKR1C3—stomach cancer	0.000103	0.000445	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—F2R—stomach cancer	0.000103	0.000443	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BMP2—stomach cancer	0.000103	0.000443	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR1A—stomach cancer	0.000102	0.00044	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKR1C3—stomach cancer	0.000101	0.000435	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PRKCB—stomach cancer	0.000101	0.000433	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ANXA1—stomach cancer	0.0001	0.000432	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR1A—stomach cancer	0.0001	0.000431	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PRKCB—stomach cancer	9.91e-05	0.000426	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ANXA1—stomach cancer	9.88e-05	0.000425	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB1—stomach cancer	9.73e-05	0.000418	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PRKCB—stomach cancer	9.7e-05	0.000417	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	9.68e-05	0.000416	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB1—stomach cancer	9.57e-05	0.000412	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	9.37e-05	0.000403	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RPS6—stomach cancer	9.29e-05	0.0004	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RPS6—stomach cancer	9.15e-05	0.000393	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PRKCB—stomach cancer	9.15e-05	0.000393	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6ST—stomach cancer	9.11e-05	0.000392	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PRKCB—stomach cancer	9e-05	0.000387	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6ST—stomach cancer	8.96e-05	0.000385	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RPS6—stomach cancer	8.96e-05	0.000385	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	8.81e-05	0.000379	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	8.78e-05	0.000377	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HBEGF—stomach cancer	8.54e-05	0.000367	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HBEGF—stomach cancer	8.4e-05	0.000361	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	8.23e-05	0.000354	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6R—stomach cancer	8.13e-05	0.000349	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RHOA—stomach cancer	8.08e-05	0.000348	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6R—stomach cancer	8e-05	0.000344	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RHOA—stomach cancer	7.95e-05	0.000342	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB2—stomach cancer	7.88e-05	0.000339	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	7.83e-05	0.000337	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	7.79e-05	0.000335	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB2—stomach cancer	7.76e-05	0.000333	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PPP2R1A—stomach cancer	7.72e-05	0.000332	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PPP2R1A—stomach cancer	7.6e-05	0.000327	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	7.59e-05	0.000327	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	7.44e-05	0.00032	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RHOA—stomach cancer	7.34e-05	0.000316	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RHOA—stomach cancer	7.22e-05	0.000311	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SMAD4—stomach cancer	7.17e-05	0.000308	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	7.1e-05	0.000305	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	7.07e-05	0.000304	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SMAD4—stomach cancer	7.06e-05	0.000303	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL8—stomach cancer	6.98e-05	0.0003	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	6.91e-05	0.000297	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	6.84e-05	0.000294	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FYN—stomach cancer	6.81e-05	0.000293	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FYN—stomach cancer	6.7e-05	0.000288	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FYN—stomach cancer	6.56e-05	0.000282	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL8—stomach cancer	6.44e-05	0.000277	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGFR2—stomach cancer	6.39e-05	0.000275	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL8—stomach cancer	6.34e-05	0.000273	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGFR2—stomach cancer	6.29e-05	0.00027	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	6.21e-05	0.000267	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	6.16e-05	0.000265	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS2—stomach cancer	5.85e-05	0.000252	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS2—stomach cancer	5.76e-05	0.000248	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CAV1—stomach cancer	5.68e-05	0.000244	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOA1—stomach cancer	5.66e-05	0.000243	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS2—stomach cancer	5.64e-05	0.000242	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CAV1—stomach cancer	5.59e-05	0.00024	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOA1—stomach cancer	5.57e-05	0.00024	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CAV1—stomach cancer	5.47e-05	0.000235	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOA1—stomach cancer	5.46e-05	0.000235	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCB—stomach cancer	5.4e-05	0.000232	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6ST—stomach cancer	5.38e-05	0.000231	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCB—stomach cancer	5.32e-05	0.000229	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6ST—stomach cancer	5.29e-05	0.000228	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	5.21e-05	0.000224	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	5.18e-05	0.000223	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APC—stomach cancer	5.17e-05	0.000222	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APC—stomach cancer	5.09e-05	0.000219	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APC—stomach cancer	4.98e-05	0.000214	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK3—stomach cancer	4.95e-05	0.000213	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK3—stomach cancer	4.87e-05	0.000209	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6R—stomach cancer	4.8e-05	0.000206	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	4.77e-05	0.000205	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6R—stomach cancer	4.72e-05	0.000203	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK1—stomach cancer	4.71e-05	0.000203	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EGFR—stomach cancer	4.71e-05	0.000203	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	4.64e-05	0.000199	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EGFR—stomach cancer	4.63e-05	0.000199	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6R—stomach cancer	4.63e-05	0.000199	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	4.54e-05	0.000195	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	4.54e-05	0.000195	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	4.5e-05	0.000194	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SERPINE1—stomach cancer	4.5e-05	0.000193	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—KRAS—stomach cancer	4.45e-05	0.000191	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	4.43e-05	0.00019	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	4.42e-05	0.00019	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—KRAS—stomach cancer	4.38e-05	0.000188	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	4.34e-05	0.000186	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RHOA—stomach cancer	4.34e-05	0.000186	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	4.33e-05	0.000186	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOS3—stomach cancer	4.29e-05	0.000185	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	4.29e-05	0.000184	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RHOA—stomach cancer	4.27e-05	0.000183	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOS3—stomach cancer	4.22e-05	0.000182	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RHOA—stomach cancer	4.18e-05	0.00018	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOS3—stomach cancer	4.14e-05	0.000178	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	4.09e-05	0.000176	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	4.02e-05	0.000173	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ERBB2—stomach cancer	4.01e-05	0.000173	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ERBB2—stomach cancer	3.95e-05	0.00017	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	3.94e-05	0.000169	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	3.87e-05	0.000166	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL8—stomach cancer	3.81e-05	0.000164	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HRAS—stomach cancer	3.78e-05	0.000163	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL8—stomach cancer	3.75e-05	0.000161	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HRAS—stomach cancer	3.72e-05	0.00016	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN1B—stomach cancer	3.72e-05	0.00016	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	3.67e-05	0.000158	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	3.66e-05	0.000157	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	3.64e-05	0.000157	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—stomach cancer	3.62e-05	0.000156	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	3.58e-05	0.000154	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—stomach cancer	3.56e-05	0.000153	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCND1—stomach cancer	3.55e-05	0.000152	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JUN—stomach cancer	3.54e-05	0.000152	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCND1—stomach cancer	3.49e-05	0.00015	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—stomach cancer	3.49e-05	0.00015	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JUN—stomach cancer	3.48e-05	0.00015	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—stomach cancer	3.44e-05	0.000148	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN1A—stomach cancer	3.43e-05	0.000148	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCND1—stomach cancer	3.42e-05	0.000147	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JUN—stomach cancer	3.41e-05	0.000147	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—stomach cancer	3.39e-05	0.000146	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	3.38e-05	0.000145	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK8—stomach cancer	3.35e-05	0.000144	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—stomach cancer	3.32e-05	0.000143	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	3.31e-05	0.000142	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK8—stomach cancer	3.3e-05	0.000142	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	3.23e-05	0.000139	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—stomach cancer	3.09e-05	0.000133	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT3—stomach cancer	3.06e-05	0.000132	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—stomach cancer	3.04e-05	0.000131	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT3—stomach cancer	3.01e-05	0.00013	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.98e-05	0.000128	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.95e-05	0.000127	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.93e-05	0.000126	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.88e-05	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MYC—stomach cancer	2.84e-05	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.82e-05	0.000121	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MYC—stomach cancer	2.8e-05	0.00012	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.78e-05	0.00012	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGFR—stomach cancer	2.78e-05	0.00012	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.74e-05	0.000118	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.74e-05	0.000118	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.74e-05	0.000118	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.68e-05	0.000115	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.68e-05	0.000115	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KRAS—stomach cancer	2.63e-05	0.000113	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.59e-05	0.000111	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.53e-05	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.42e-05	0.000104	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.38e-05	0.000102	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TP53—stomach cancer	2.34e-05	0.0001	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.33e-05	0.0001	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TP53—stomach cancer	2.3e-05	9.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.25e-05	9.68e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HRAS—stomach cancer	2.23e-05	9.61e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HRAS—stomach cancer	2.2e-05	9.45e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.15e-05	9.26e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—stomach cancer	2.14e-05	9.19e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—stomach cancer	2.1e-05	9.05e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.06e-05	8.86e-05	CbGpPWpGaD
